Irving, J., Matheson, E., Minto, L., Blair, H., Case, M., Halsey, C., . . . Eckert, C. (2014). Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood.
Citação norma ChicagoIrving, Julie, et al. "Ras Pathway Mutations Are Prevalent in Relapsed Childhood Acute Lymphoblastic Leukemia and Confer Sensitivity to MEK Inhibition." Blood 2014.
Citação norma MLAIrving, Julie, et al. "Ras Pathway Mutations Are Prevalent in Relapsed Childhood Acute Lymphoblastic Leukemia and Confer Sensitivity to MEK Inhibition." Blood 2014.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.